Secarna to Present Showcasing the Innovation Potential of the LNAplus Platform
17 Oct 2023 //
ACCESSWIRE
Secarna and SciNeuro Enter into Agreement in the Field of CNS Diseases
27 Mar 2023 //
ACCESSWIRE
Secarna, SciNeuro Enter Research Agreement for CNS Diseases
27 Mar 2023 //
CONTRACT PHARMA
Evotec Achieves Programme Designation in Neuroscience Collaboration with BMS
12 Apr 2022 //
ACCESSWIRE
Secarna and Achilles Sign Agreement to Develop Optimized T Cell Therapies
10 Nov 2021 //
BIOSPACE
Secarna, Denali Expand Partnership for Novel ASO Therapeutics in CNS Diseases
26 Oct 2021 //
BIOSPACE
Secarna to Identify Biomarkers for Personalized Cancer Immunotherapy with ASOs
25 Oct 2021 //
BIOSPACE
Secarna: Secarna and Evotec Expand Strategic Partnership
03 Sep 2021 //
NASDAQ
Secarna, Evotec Form Strategic Antisense Alliance
05 Aug 2020 //
CONTRACTPHARMA